My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
October 2009
Vol. 19 No. 10
Global ID
Is Europe Moving Ahead of the U.S. on Antimicrobial Resistance Policy Efforts?
New Reports Highlight Antibiotic Resistance, Ways to Spur Drug Development

Two recent European reports, reminiscent of IDSA’s 2004 “Bad Bugs, No Drugs” report,  describe the growing problem of antimicrobial resistance in Europe and highlight possible strategies, including incentives, to stimulate the development of new antibiotics. Both were part of an international conference sponsored by the European Union (EU) and held Sept. 17 in Stockholm.

The first report, drafted by the European Center for Disease Prevention and Control and the European Medicines Agency, analyzes the growing gap between the resistance problem in the EU and the diminishing antibacterial pipeline. The report outlines the scope of the burden posed by drug resistance in Europe, where approximately 25,000 people die each year from just five infections: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium, third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae, and carbapenem-resistant Pseudomonas aeruginosa. These five infections result in about 2.5 million extra hospital days and more than 900 million Euros (approximately $1.4 billion) in additional hospital costs, according to the report’s authors, who call for a European and global strategy to combat antibiotic resistance.

The other major report, from the London School of Economics and Political Science (LSEPS), outlines potential policy options, including financial and other incentives to spur antibacterial drug and related diagnostic research and development. The analysis, which generated media coverage on the websites of CNN and TIME magazine, includes strategies such as direct research funding and tax incentives, intellectual property mechanisms and monetary prizes, and possible regulatory tools, among other possible ways to encourage the much needed research and development in this area.

IDSA is looking for opportunities to leverage the EU’s advances in this policy area to motivate greater U.S. action and already has called upon the Food and Drug Administration (FDA) to commission a study similar to the LSEPS report that will analyze policy options in this country. In early November, EU and U.S. political leaders plan to meet to discuss these issues at a summit in Washington, D.C., where President Obama and the Swedish prime minister (Sweden currently holds the EU presidency) are expected to agree to establish a joint transatlantic task force on antimicrobial resistance. IDSA will continue to monitor these discussions and weigh in as appropriate. For more information about the Society’s efforts to address antibiotic resistance, see IDSA’s website.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
From the President: The Importance of Vaccination
IDSA Strengthens Mandatory Influenza Immunization Policy for HCWs
IDSA Journal Club
Patient Care and Science
ACIP Makes Recommendations for HPV Vaccine Use in Males
NIAID Considers Revamp to Clinical Trials Infrastructure, Works to Address Research Barriers
EIN: H1N1 and Seasonal Influenza Vaccination Questions
Drug Approvals, Recalls, Adverse Events Update
Practice Management
How to Bill for H1N1 Vaccine
Global ID
Annual Meeting Features Timely Global Health Sessions
Global Center Calls for Bold New HIV Treatment Targets
Where Will PEPFAR Find 140,000 New Health Care Workers?
Is Europe Moving Ahead of the U.S. on Antimicrobial Resistance Policy Efforts?
Policy and Advocacy
CDC Issues Revised Guidance for Preventing H1N1 in Health Facilities
IDSA Weighs In Regarding New Physician Payment Models
Congress Extends Ryan White Program Until 2013
Your Colleagues
Announcing the New IDSA/HIVMA Board Members
Congratulations to the 2009 Society Award Winners!
IDSA Congratulates the 2009 Joint Research Award Winners
Members on the Move
Welcome, New Members!
Education and Resources
“Ask the Coder” Answers CPT Questions

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.